Credit: Anastasiia/AdobeStock

What implantable sensor system became the first FDA-cleared continuous glucose monitor designed to remain in the body for up to 90 days?

Senseonics’ Eversense CGM system. The system uses a small sensor that is implanted just under the skin during an outpatient procedure. After it is implanted, the sensor regularly measures glucose levels in adults with diabetes for up to 90 days. Source: www.fda.gov 

Magazine cover

The Medical Design Briefs trivia questions first appear in the Medical Design Briefs e-Source newsletter. If you would like to be among the first to see the latest question, click the subscribe button below.

Read more from the trivia archives here.

Topics:
Medical Product Development Sensors Wearables

More From SAE Media Group